Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Therapies02:49

Cancer Therapies

7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

The development of activity-based mannanase probes.

Chemical science·2026
Same author

A chemoproteomic biotechnological toolkit for resolving xylanase specificity in decorated xylan.

Nature communications·2026
Same author

Oseltamivir aziridines are potent influenza neuraminidase inhibitors and imaging agents.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Fully protected pyrophosphates <i>via</i> phosphorobromidates for the synthesis of biopolymers.

Chemical science·2026
Same author

Catalyzing Carbohydrate Cleavage: Glycosidases and Their Mechanisms.

Chemical reviews·2026
Same author

Setting higher standards for reports of microbial species in human cancers.

Nature cancer·2026

関連する実験動画

Updated: Sep 9, 2025

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
10:26

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

8.6K

組織に深く浸透するためにアントラサイクリンを操作し,糖質組織への影響

Erik R Abels1, Esther Ter Linden1, Jos H T Rohling1

  • 1Department of Cell and Chemical Biology and Oncode Institute, Leiden University Medical Center, Leiden 2300 RC, The Netherlands.

Proceedings of the National Academy of Sciences of the United States of America
|September 3, 2025
PubMed
まとめ

薬が腫瘍に浸透することは 効果の鍵です アントラサイクリン がん薬は酸性腫瘍の状態に深く浸透しますが,これは有効性を低下させ,改変ががん治療を改善することを示唆します.

キーワード:
アントラサイクリンドクソルビシン薬剤耐性グリコリス組織への浸透

さらに関連する動画

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
08:52

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Published on: January 19, 2018

14.1K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

関連する実験動画

Last Updated: Sep 9, 2025

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
10:26

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

8.6K
Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
08:52

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Published on: January 19, 2018

14.1K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

科学分野:

  • 薬理学について
  • 癌 生物学
  • 薬物の配達

背景:

  • 薬の標的組織への浸透は,治療効果にとって極めて重要です.
  • 腫瘍のような複雑な生物学的環境における 薬物の拡散を理解することは 依然として課題です
  • アントラサイクリンは重要な化学療法剤ですが,その組織への浸透は完全に理解されていません.

研究 の 目的:

  • アントラサイクリン がん薬の組織浸透のダイナミクスを調査する.
  • 薬の浸透深さを支配する物理化学的性質を特定する.
  • 腫瘍の微小環境が 薬の投与と有効性に影響するかを調べる

主な方法:

  • 固有の光を用いて薬の運命を視覚化するために 細胞ベースの球形モデルを使用した.
  • 生理学的環境を模倣した異なるpH条件でのアントラサイクリン浸透度を調査した.
  • 化学的性質と浸透深さの相関を評価した.

主要な成果:

  • アントラサイクリンには,細胞の外層に浸透する中間的水性が示された.
  • 酸性状態は球体への浸透を強めたが,細胞への侵入と細胞毒性を減少させた.
  • モラー屈折度,トポロジカルな極面面積,そして水溶性は,浸透深さの重要な決定因子でした.

結論:

  • 腫瘍の微小環境の酸性および甘解性条件は,アントラサイクリン浸透を制限し,薬剤耐性を引き起こす可能性があります.
  • 特定された物理化学的性質に基づいてアントラサイクリンを改変すると,深部にある腫瘍への薬物投与が強化される可能性があります.
  • この研究は,アントラサイクリンベースの治療法,特に臓がんのような挑戦的な標的の改善のための洞察を提供します.